Opportunities Preloader

Please Wait.....

Report

Next Generation Sequencing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits), By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing), By Usage Area (Clinical, Research), By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others), By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others), By Region and Competition

Market Report I 2023-08-01 I 111 Pages I TechSci Research

Next Generation Sequencing Kits market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.
Growing Advancements in NGS
Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.
For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient's complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

Growing Demand for Early Detection of Chronic Diseases

For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn't require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

Market Segmentation

Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

Recent Development
- In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
- In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.

Market Players
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.
Report Scope:
In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Next Generation Sequencing Kits Market, By Workflow:
o Library Preparation
o Cluster Generation
o Sequencing Reagents Kits
- Next Generation Sequencing Kits Market, By Sequencing Type:
o WES and WGS
o Targeted Sequencing
o Long Read Sequencing
o Other Sequencing
- Next Generation Sequencing Kits Market, By Usage Area:
o Clinical
o Research
- Next Generation Sequencing Kits, By Application:
o Oncology
o Rare Diseases
o Genetic Disorders
o Reproductive Health
o Others
- Next Generation Sequencing Kits, By End User:
o Academic and Research Institutions
o Pharmaceutical and Biotechnology Companies
o Clinical and Diagnostic Laboratories
o Others
- Next Generation Sequencing Kits Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
o Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing Kits Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
5.2.3. By Usage Area (Clinical, Research)
5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1 By Workflow
5.3.2 By Sequencing Type
5.3.3 By Usage Area
5.3.4 By Application
5.3.5 By End User
5.3.6 By Region
6. North America Next Generation Sequencing Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
6.2.3. By Usage Area (Clinical, Research)
6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing Kits Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Workflow
6.3.1.2.2. By Sequencing Type
6.3.1.2.3. By Usage Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Next Generation Sequencing Kits Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Workflow
6.3.2.2.2. By Sequencing Type
6.3.2.2.3. By Usage Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Workflow
6.3.3.2.2. By Sequencing Type
6.3.3.2.3. By Usage Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Next Generation Sequencing Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
7.2.3. By Usage Area (Clinical, Research)
7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Next Generation Sequencing Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Workflow
7.3.1.2.2. By Sequencing Type
7.3.1.2.3. By Usage Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Germany Next Generation Sequencing Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Workflow
7.3.2.2.2. By Sequencing Type
7.3.2.2.3. By Usage Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Workflow
7.3.3.2.2. By Sequencing Type
7.3.3.2.3. By Usage Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Next Generation Sequencing Kits Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Workflow
7.3.4.2.2. By Sequencing Type
7.3.4.2.3. By Usage Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Next Generation Sequencing Kits Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Workflow
7.3.5.2.2. By Sequencing Type
7.3.5.2.3. By Usage Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Next Generation Sequencing Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
8.2.3. By Usage Area (Clinical, Research)
8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Workflow
8.3.1.2.2. By Sequencing Type
8.3.1.2.3. By Usage Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Next Generation Sequencing Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Workflow
8.3.2.2.2. By Sequencing Type
8.3.2.2.3. By Usage Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Next Generation Sequencing Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Workflow
8.3.3.2.2. By Sequencing Type
8.3.3.2.3. By Usage Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Workflow
8.3.4.2.2. By Sequencing Type
8.3.4.2.3. By Usage Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Next Generation Sequencing Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Workflow
8.3.5.2.2. By Sequencing Type
8.3.5.2.3. By Usage Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Next Generation Sequencing Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
9.2.3. By Usage Area (Clinical, Research)
9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Workflow
9.3.1.2.2. By Sequencing Type
9.3.1.2.3. By Usage Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Workflow
9.3.2.2.2. By Sequencing Type
9.3.2.2.3. By Usage Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Workflow
9.3.3.2.2. By Sequencing Type
9.3.3.2.3. By Usage Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Next Generation Sequencing Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
10.2.3. By Usage Area (Clinical, Research)
10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Workflow
10.3.1.2.2. By Sequencing Type
10.3.1.2.3. By Usage Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Workflow
10.3.2.2.2. By Sequencing Type
10.3.2.2.3. By Usage Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Next Generation Sequencing Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Workflow
10.3.3.2.2. By Sequencing Type
10.3.3.2.3. By Usage Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing advancement in NGS
11.1.2 Growing Demand for Early Detection of Chronic Diseases
11.2. Challenges
11.2.1 Lack of skilled professionals and infrastructure
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Next Generation Sequencing Kits Market: SWOT Analysis
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.5.1. Agilent Technologies, Inc.
15.5.2. Bio-Rad Laboratories, Inc.
15.5.3. BGI Group.
15.5.4. Creative Biogene
15.5.5. Danaher.
15.5.6. F. Hoffmann-La Roche Ltd.
15.5.7. Hologic, Inc.
15.5.8. Illumina, Inc.
15.5.9. Oxford Nanopore Technologies plc.
15.5.10. Pacific Biosciences of California, Inc.
15.5.11. PerkinElmer Inc.
16. Strategic Recommendations

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE